| http://www.w3.org/ns/prov#value | - Pulmatrix's PUR118 Demonstrates Potential to Reduce Acute Exacerbations of the Lung Associated with Progressive Respiratory Diseases, such as COPD, Asthma, CF, and Respiratory Infections Rats on Antidepressants Showed Signs of Autism, University of Mississippi Medical Center Study Pulmatrix Wins $14 Million to Back Drug For Cystic Fibrosis And Other Lung Ailments Experimental Vaccine Protects Monk
|
